Invention Grant
- Patent Title: Tricyclic compounds as anticancer agents
-
Application No.: US15661373Application Date: 2017-07-27
-
Publication No.: US10112941B2Publication Date: 2018-10-30
- Inventor: Derek J. Norris , George V. Delucca , Ashvinikumar V. Gavai , Francis Y. Lee , John S. Tokarski
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Elliott Korsen
- Main IPC: C07D471/04
- IPC: C07D471/04 ; A61K31/437
Abstract:
The present invention is directed to tricyclic compounds, pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders.
Public/Granted literature
- US20170327498A1 NOVEL TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS Public/Granted day:2017-11-16
Information query
